Patients Continue To Demand Cheap Generic Life-Saving Drugs From India

News: China has a large demand for low-priced generic life-saving drugs manufactured in India, reports NZweek, citing the General Administration of Customs of China. Chinese smugglers and patients are finding ways to get the drugs despite the Chinese government banning their use, deeming them fake. Many patients in China buy anticancer drugs from pharmacies in India online at a much cheaper rate, revealed an unidentified buyer. Several generic drugs produced by Indian drugmakers are comparable to those made by international drug giants, such as Indian drugmaker Cipla's Soranib for liver cancer treatment. Costing CNY2,000(US$326.3), it is an Indian equivalent to German drugmaker Bayer's Nexavar (sorafenib), which costs CNY50,000(US$8,157.5) a month.

This article is tagged to:
Sector: Pharmaceuticals & Healthcare
Geography: China

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.